Leaflet AFLEN 300mg capsules

Indicated for: prevention of atherothrombotic events

Route of administration: oral

Substance: triflusal (anticoagulant)

ATC: B01AC18 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Triflusal is an antiplatelet medication used to prevent thrombotic events such as myocardial infarction and ischemic stroke. It works by inhibiting cyclooxygenase-1 (COX-1) activity and increasing prostacyclin levels, thereby reducing blood clot formation.

Triflusal is particularly indicated for patients with a high cardiovascular risk, serving as an alternative to aspirin for those who do not tolerate it well. It is used in the secondary prevention of strokes and other arterial thrombotic events.

Compared to aspirin, triflusal has a lower risk of gastrointestinal side effects and bleeding, making it a safer option for certain patient groups. However, its use should be carefully monitored, and the dosage should be adjusted based on the individual needs of the patient.

General data about AFLEN 300mg

  • Substance: triflusal
  • Date of latest medicines list: 01-06-2026
  • Product code: W53412001
  • Concentration: 300mg
  • Pharmaceutical form: capsules
  • Quantity: 50
  • Product type: Original
  • Price: 39.97 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: GALENICA S.A. - GRECIA
  • Holder: GALENICA S.A. - GRECIA
  • Number: 9089/2016/01
  • Shelf life: 4 years

Compensation lists for AFLEN 300mg Galenica

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

39.97 RON

19.99 RON

19.99 RON